Related Experiment Video
Updated: Jul 2, 2025
10:16
Optimization of Flow Cytometric Sorting Parameters for High-Throughput Isolation and Purification of Small Extracellular Vesicles
Published on: January 20, 2023
3.1K
Peptide-based capture-and-release purification of extracellular vesicles and statistical algorithm enabled quality
Zachary F Greenberg1, Samantha Ali1, Thomas D Schmittgen1
1Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Biorxiv : the Preprint Server for Biology
|February 19, 2024
Summary
Researchers developed a new method to isolate homogeneous extracellular vesicles (EVs) and a quality index (EQI) for standardized EV assessment. This improves the identification of tumor biomarkers for cancer diagnostics.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- Circulating extracellular vesicles (EVs) are crucial for tumor biomarker discovery.
- Current EV isolation methods yield heterogeneous populations, hindering clinical translation.
- Standardized quality assessment of isolated EVs is essential for reliable downstream analysis.
Approach:
- Developed the ExoQuality Index (EQI), a statistical algorithm integrating multiple EV characterizations (size, concentration, zeta potential, protein, RNA) for quality assessment.
- Introduced a novel capture-release isolation method (ExCy) using pH-responsive peptide-conjugated magnetic beads for homogeneous EV isolation.
- Applied a novel workflow to analyze EV total RNAs from pancreatic cancer patient plasma using next-generation sequencing (NGS).
Key Points:
- The EQI enables direct quality assessment and comparison of different EV isolation methods.
- The ExCy method provides simple, fast, and homogeneous EV isolation from various biofluids.
- Bioinformatic analysis revealed improved identification of tumor-associated molecular markers with the new approach.
Conclusions:
- The study establishes a workflow for rigorous EV sample preparation and analysis.
- Enhanced human mRNA coverage in pancreatic cancer pathways was observed using the novel EV isolation and quality assessment strategy.
- This work advances reliable EV quality assessment and supports clinical translation of EV-based diagnostics.
